SymCheck

SymCheck is a digital health and remote patient monitoring company focused on AI-driven mobile biometric screening and health assessment. Its software enables users to capture vital signs and wellness metrics from standard mobile devices, supporting remote patient monitoring, workforce health screening, and compliance workflows. The business appears to operate as a commercial software platform rather than a therapeutics developer, with no disclosed drug pipeline. SymCheck was acquired by CLX Health in late 2021 along with parent company Yorn, and the brand continues to be used within the SiriusIQ and CLX Health ecosystem. Current product positioning emphasizes vision-based health assessment, analytics, and cloud-enabled monitoring for healthcare and other mission-critical industries.